Key result
An electronic health record integrated home blood pressure monitor will be compared to a nonintegrated monitor for improving systolic blood pressure at 6 months in a planned trial of 660 participants.
Why the study?
There is limited evidence comparing whether an electronic health record integrated blood pressure monitor is superior to a nonintegrated monitor for hypertension management.
Does an electronic health record integrated home blood pressure monitor improve systolic blood pressure in patients with hypertension compared to a nonintegrated blood pressure monitor?
RCT (n=660)
Randomized
Yes
Does an electronic health record integrated home blood pressure monitor improve systolic blood pressure in patients with hypertension compared to a nonintegrated blood pressure monitor?
This protocol describes a pragmatic trial to determine if EHR-integrated home blood pressure monitoring improves systolic blood pressure more than non-integrated monitoring in patients with hypertension.
BACKGROUND Hypertension is a major contributor to various adverse health outcomes. Although previous studies have shown the benefits of home blood pressure (BP) monitoring over office-based measurements, there is limited evidence comparing the effectiveness of whether a BP monitor integrated into the electronic health record is superior to a nonintegrated BP monitor. OBJECTIVE In this paper, we describe the protocol for a pragmatic multisite implementation of a quality improvement initiative directly comparing integrated to nonintegrated BP monitors for hypertension improvement. METHODS We will conduct a randomized, comparative effectiveness trial at 3 large academic health centers across California. The 3 sites will enroll a total of 660 participants (approximately n=220 per site), with 330 in the integrated BP monitor arm and 330 in the nonintegrated BP control arm. The primary outcome of this study will be the absolute difference in systolic BP in mm Hg from enrollment to 6 months. Secondary outcome measures include binary measures of hypertension (controlled vs uncontrolled), hypertension-related health complications, hospitalizations, and death. The list of possible participants will be generated from a central data warehouse. Randomization will occur after enrollment in the study. Participants will use their assigned BP monitor and join site-specific hypertension interventions. Cross-site learning will occur at regular all-site meetings facilitated by the University of California, Los Angeles Value-Based Care Research Consortium. A pre- and poststudy questionnaire will be conducted to further evaluate participants’ perspectives regarding their BP monitor. Linear mixed effects models will be used to compare the primary outcome measure between study arms. Mixed effects logistic regression models will be used to compare secondary outcome measures between study arms. RESULTS The study will start enrolling participants in the second quarter of 2023 and will be completed by the first half of 2024. Results will be published by the end of 2024. CONCLUSIONS This pragmatic trial will contribute to the growing field of chronic care management using remote monitoring by answering whether a hypertension intervention coupled with an electronic health record integrated home BP monitor improves patients’ hypertension better than a hypertension intervention with a nonintegrated BP monitor. The outcomes of this study may help health system decision makers determine whether to invest in integrated BP monitors for vulnerable patient populations. CLINICALTRIAL ClinicalTrials.gov NCT05390502; clinicaltrials.gov/study/NCT05390502 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/45915
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) conducted an RCT in Hypertension (n=660). Electronic health record integrated home BP monitor vs. Nonintegrated BP monitor was evaluated on Absolute difference in systolic BP in mm Hg from enrollment to 6 months. An electronic health record integrated home blood pressure monitor will be compared to a nonintegrated monitor for improving systolic blood pressure at 6 months in a planned trial of 660 participants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: